These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 7678975

  • 1. Palliative treatment of hepatocellular carcinoma with transcatheter arterial embolization.
    Savastano S, Feltrin GP, Neri D, da Pian P, Chiesura-Corona M, Roman E, Battaglia G, Gerunda G, Lise M, Miotto D.
    Acta Radiol; 1993 Jan; 34(1):26-9. PubMed ID: 7678975
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A comparison of chemoembolization with conventional chemotherapy and symptomatic treatment in cirrhotic patients with hepatocellular carcinoma.
    Bayraktar Y, Balkanci F, Kayhan B, Uzunalimoglu B, Gokoz A, Ozisik Y, Gurakar A, Van Thiel DH, Firat D.
    Hepatogastroenterology; 1996 Jan; 43(9):681-7. PubMed ID: 8799415
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
    Marelli L, Shusang V, Buscombe JR, Cholongitas E, Stigliano R, Davies N, Tibballs J, Patch D, Meyer T, Burroughs AK.
    J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
    [Abstract] [Full Text] [Related]

  • 7. [Chemoembolization in the therapy of hepatocarcinoma. A 3-year experience].
    Savastano S, Feltrin GP, Miotto D, Chiesura-Corona M, Torraco A, Castellan L, Roman E, el Khatib AB, Cannito F, Sandri P.
    Radiol Med; 1992 Nov; 84(5):608-12. PubMed ID: 1335590
    [Abstract] [Full Text] [Related]

  • 8. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B, Yu J, Wang L, Li C, Zhou T, Zhai L, Xing L.
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [Abstract] [Full Text] [Related]

  • 9. Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts.
    Tesdal IK, Wikström M, Flechtenmacher C, Filser T, Dueber C.
    Cardiovasc Intervent Radiol; 2006 Aug; 29(5):778-84. PubMed ID: 16779690
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Analysis of survival in 240 patients with unresectable primary hepatocellular carcinoma treated with hepatic artery chemo-embolization].
    Cheng L, Wang Z, Cai F.
    Zhonghua Zhong Liu Za Zhi; 1996 Sep; 18(5):362-4. PubMed ID: 9387276
    [Abstract] [Full Text] [Related]

  • 12. Long-term outcomes of transcatheter arterial chemoembolization with autologous blood clot for unresectable hepatocellular carcinoma.
    Gunji T, Kawauchi N, Akahane M, Watanabe K, Kanamori H, Ohnishi S.
    Int J Oncol; 2002 Aug; 21(2):427-32. PubMed ID: 12118341
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Styrene maleic acid neocarzinostatin-transcatheter embolization for hepatocellular carcinoma--third report].
    Hasegawa I, Hirashima N.
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):253-9. PubMed ID: 11865632
    [Abstract] [Full Text] [Related]

  • 15. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
    Lubienski A, Bitsch RG, Schemmer P, Grenacher L, Düx M, Kauffmann GW.
    Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
    [Abstract] [Full Text] [Related]

  • 16. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.
    Dohmen K, Shirahama M, Shigematsu H, Miyamoto Y, Torii Y, Irie K, Ishibashi H.
    Hepatogastroenterology; 2001 Dec; 48(41):1409-15. PubMed ID: 11677976
    [Abstract] [Full Text] [Related]

  • 17. Significance of reduction surgery in multidisciplinary treatment of advanced hepatocellular carcinoma with multiple intrahepatic lesions.
    Wakabayashi H, Ushiyama T, Ishimura K, Izuishi K, Karasawa Y, Masaki T, Watanabe S, Kuriyama S, Maeta H.
    J Surg Oncol; 2003 Feb; 82(2):98-103. PubMed ID: 12561065
    [Abstract] [Full Text] [Related]

  • 18. Multimodality treatment for patients with hepatocellular carcinoma: a single institution retrospective series.
    Takano S, Watanabe Y, Ohishi H, Kono S, Nakamura M, Kubota N, Iwai S.
    Eur J Surg Oncol; 2000 Feb; 26(1):67-72. PubMed ID: 10718183
    [Abstract] [Full Text] [Related]

  • 19. Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead.
    Malagari K, Alexopoulou E, Chatzimichail K, Hall B, Koskinas J, Ryan S, Gallardo E, Kelekis A, Gouliamos A, Kelekis D.
    Abdom Imaging; 2008 Feb; 33(5):512-9. PubMed ID: 17938995
    [Abstract] [Full Text] [Related]

  • 20. [Non-surgical (medical) treatment of hepatocellular carcinoma (HCC)].
    Tanikawa K.
    Gan To Kagaku Ryoho; 1989 Jan; 16(1):34-9. PubMed ID: 2536269
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.